NCT04281251

Brief Summary

This is a prospective pilot study on the efficacy of endoscopic therapy for adult uncomplicated acute appendicitis. In recent years, antibiotics treatment has been a new alternative approach to surgical appendicectomy for acute appendicitis, however, there is a risk of failed antibiotics treatment and chance of recurrent appendicitis. Endoscopic therapy of acute appendicitis (ERAT) has been recently described that involves colonoscopic insertion of plastic stent and removal of appendicolith. The investigators conduct this pilot study to investigate the feasibility, technical and clinical success rate of endoscopic retrograde appendicitis therapy among adult patients with uncomplicated acute appendicitis. 20 patients would be recruited for the pilot study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

1.6 years

First QC Date

February 20, 2020

Last Update Submit

February 7, 2023

Conditions

Keywords

appendicitisendoscopic drainage

Outcome Measures

Primary Outcomes (1)

  • Clinical success rate

    defined as completion of both endoscopic procedures without need for surgery or complications related to acute appendicitis

    30 days

Secondary Outcomes (4)

  • Technical success rate

    30 days

  • Rate of recurrent acute appendicitis, up to 1 year of index attack

    1 year

  • Rate of adverse events related to endoscopic procedures

    30 days

  • Scale of post-operative pain

    7 days

Study Arms (1)

ERAT arm

EXPERIMENTAL

This is the treatment arm where endoscopic therapy of acute appendicitis would be performed

Procedure: Endoscopic retrograde appendicitis therapy

Interventions

Colonoscopy would be introduced until visualization of the appendiceal orifice. Catheter would be placed in the appendix and decompression performed. After removal of appendicolith, plastic stent would be placed for drainage of appendix. For patients successfully treated with initial endoscopic drainage, they would be re-admitted at 1 weeks after index procedure for repeat colonoscopy. After reaching the appendiceal orifice, the previous plastic stent would be removed. A contrast appendicogram would be repeated by introducing a wire-guided catheter in the appendix, and any residual fecalith would be removed. Finally, a repeat contrast appendicogram would be performed to confirm complete clearance of fecalith.

ERAT arm

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients emergency admitted for suspected acute appendicitis
  • Age 18 - 70
  • Computed Tomography of the abdomen with contrast confirmed uncomplicated appendicitis, as evidenced by presence of a dilated, thickened wall appendix without perforation, abscess or gangrene.

You may not qualify if:

  • History of previous appendicitis
  • Evidence of perforation, abscess or gangrene of appendix on CT scan
  • Significant paralytic ileus as evidenced by dilated bowel loops on imaging
  • Evidence of co-existing acute surgical pathologies on the CT scan
  • Allergic to bowel preparation solution (Polyethylene glycol)
  • Marked electrolyte abnormalities, significant renal impairment (CrCl \<30ml/min)
  • Coagulopathy (INR \>1.5, platelet \<50)
  • Pregnancy, or contraindication to fluoroscopy
  • Other cases deemed by the examining physician as unsuitable for safe treatment
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Appendicitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single arm case series
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Consultant

Study Record Dates

First Submitted

February 20, 2020

First Posted

February 24, 2020

Study Start

June 1, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations